Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Asthma exacerbation profile of benralizumab for severe eosinophilic asthma (the BenRex study): a multicentre, prospective cohort study.
Journal: The Lancet. Respiratory medicine
Published: October 30, 2025
Mepolizumab for COPD with Eosinophilic Phenotype following Hospitalization.
Journal: NEJM evidence
Published: April 30, 2025
Artificial neural network risk prediction of COPD exacerbations using urine biomarkers.
Journal: ERJ open research
Published: August 14, 2024
Effect of benralizumab treatment on the airway microbiome in COPD.
Journal: ERJ open research
Published: August 10, 2024
Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease (COPD-ST2OP): a phase 2a, placebo-controlled trial.
Journal: The Lancet. Respiratory medicine
Published: October 23, 2021
The sputum microbiome is distinct between COPD and health, independent of smoking history.
Journal: Respiratory research
Published: April 09, 2020
Detection of Cell-Dissociated Non-Typeable Haemophilus influenzae in the Airways of Patients with Chronic Obstructive Pulmonary Disease.
Journal: International journal of chronic obstructive pulmonary disease
Published: January 24, 2020
Neutrophil elastase as a biomarker for bacterial infection in COPD.
Journal: Respiratory research
Published: May 07, 2019
Sputum Streptococcus pneumoniae is reduced in COPD following treatment with benralizumab.
Journal: International journal of chronic obstructive pulmonary disease
Published: December 14, 2018
Sputum Moraxella catarrhalis strains exhibit diversity within and between COPD subjects.
Journal: International journal of chronic obstructive pulmonary disease
Published: December 05, 2018
Last Updated: 09/26/2026